Could a blood pressure drug help babies' hearts heal themselves?
NCT ID NCT04713657
Summary
This study is testing whether propranolol, a medication already used in infants for other conditions, can help stimulate the growth of new heart muscle cells in babies born with serious heart defects. Researchers will enroll 40 infants under 60 days old who have tetralogy of Fallot or similar conditions and are scheduled for surgery. They'll examine heart tissue removed during surgery to see if the medication increased cell growth, which could lead to better long-term heart function.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TETRALOGY OF FALLOT are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Children's Hospital of Philadelphia
RECRUITINGPhiladelphia, Pennsylvania, 19104, United States
Contact Email: •••••@•••••
Contact Email: •••••@•••••
-
Upmc Children'S Hospital of Pittsburgh
RECRUITINGPittsburgh, Pennsylvania, 15224, United States
Contact
Contact Email: •••••@•••••
-
Weill Cornell Medicine
RECRUITINGNew York, New York, 10065, United States
Contact
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.